원격 환자 모니터링 시스템 시장 분석 및 예측(-2035년) : 유형, 제품, 서비스, 기술, 구성 요소, 용도, 디바이스, 전개, 최종 사용자, 기능

The global Remote Patient Monitoring Systems Market is projected to grow from $8.2 billion in 2025 to $38.5 billion by 2035, at a compound annual growth rate (CAGR) of 16.7%. Remote patient monitoring adoption has expanded substantially within Medicare-supported care. CMS states that Medicare broadly covers remote physiologic monitoring for acute and chronic conditions when connected medical devices collect and electronically transmit patient data, while its current guidance emphasizes device supply, patient education, and treatment management as core components. A national analysis of Medicare professional-service claims found that RPM services increased from 160,595 in 2019 to 5.52 million in 2023, demonstrating sustained utilization expansion. CMS also reported that remote monitoring participation had increased significantly each year since Medicare coverage began in 2018, reinforcing the markets transition toward digitally enabled, home-based care delivery.

Wearable devices include smart patches, watches, continuous glucose monitors, pulse oximeters, and connected biosensors that continuously or periodically capture physiological parameters while supporting mobility and patient engagement. Implantable devices provide longer-term monitoring through internally positioned sensors or therapeutic systems, particularly for cardiac and other chronic conditions requiring persistent data collection. External monitoring devices encompass connected blood-pressure monitors, weight scales, ECG systems, and respiratory monitors used in home-based care. Increasing integration of wireless connectivity, miniaturized sensors, automated data transmission, and analytics is strengthening clinical utility. Wearable and external systems are expected to maintain broad adoption because of their scalability, usability, and suitability for decentralized care.

Smartphones function as primary interfaces for RPM ecosystems by receiving device-generated measurements, supporting patient communication, displaying health trends, and enabling mobile applications for care management. Tablets provide larger interfaces for patients and caregivers while supporting telehealth interactions, monitoring dashboards, and data visualization, particularly in home-care environments. Desktop monitors remain important within hospitals, clinics, command centers, and provider organizations because they support comprehensive visualization and clinical interpretation of remotely collected information. Increasing interoperability between connected medical devices, mobile applications, cloud platforms, and electronic health records is expanding the role of these devices. Smartphone-centered architectures are particularly positioned for scalable patient engagement and decentralized monitoring.

Geographical Overview

North America maintains a strong market position through extensive digital-health infrastructure, established reimbursement mechanisms, advanced healthcare delivery networks, and high penetration of connected medical technologies. The United States represents the principal demand base, supported by widespread chronic disease management requirements and increasing integration of RPM into primary care, cardiology, diabetes management, and home healthcare. CMS reimbursement policies provide an important commercial foundation by recognizing remote physiologic monitoring and specifying requirements for connected medical devices and electronically transmitted data. Healthcare providers are also expanding virtual-care capabilities and centralized monitoring workflows, strengthening demand for interoperable devices and platforms.

Asia Pacific is developing a broader RPM ecosystem as healthcare digitization, smartphone penetration, connected-device adoption, and investments in virtual care accelerate across major economies. Japan, China, South Korea, India, Australia, and Southeast Asian markets are expanding digital health infrastructure while providers increasingly explore remote management for chronic diseases and aging populations. Local technology companies, medical-device manufacturers, hospitals, and telecommunications providers are supporting ecosystem development through connected platforms and home-care solutions. Government-backed digital-health initiatives and improving healthcare connectivity are encouraging adoption beyond major urban centers. Continued investment in interoperable platforms, affordable monitoring devices, and telehealth infrastructure is expected to widen the addressable patient base.

Key Trends and Drivers

From Episodic Checks to Always-On Patient Monitoring:

RPM is evolving from episodic data collection toward continuous, connected, and analytics-enabled care models. Wearable sensors, connected medical devices, mobile applications, cloud platforms, and artificial intelligence are increasingly integrated to generate longitudinal patient profiles and identify clinically relevant changes. Greater interoperability with electronic health records and digital clinical workflows is also enabling providers to incorporate remotely generated information into routine decision-making, while patient-facing applications are improving engagement and adherence. CMS guidance increasingly frames RPM around connected device use, automatic data transmission, interpretation, and treatment management, reinforcing the shift toward structured digital care pathways.

Chronic Disease Burden Accelerates the Shift to Remote Care:

The increasing burden of chronic and acute conditions is driving healthcare providers toward scalable monitoring models that extend clinical oversight beyond hospitals and outpatient facilities. RPM enables clinicians to obtain physiological information from patients in their homes, support earlier intervention, adjust treatment based on remotely collected data, and reduce dependence on frequent in-person encounters. Growing acceptance of value-oriented and home-based care is further encouraging providers and payers to incorporate connected monitoring into chronic disease management. The expansion of Medicare-supported RPM services and formalized reimbursement requirements has strengthened provider awareness and created a clearer pathway for integrating remote monitoring into established care models.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Component
• 2.6 Key Market Highlights by Application
• 2.7 Key Market Highlights by Device
• 2.8 Key Market Highlights by Deployment
• 2.9 Key Market Highlights by End User
• 2.10 Key Market Highlights by Functionality

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Wearable Devices
  • 4.1.2 Implantable Devices
  • 4.1.3 Stationary Devices
  • 4.1.4 Portable Devices
  • 4.1.5 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Blood Pressure Monitors
  • 4.2.2 Glucose Monitors
  • 4.2.3 Heart Rate Monitors
  • 4.2.4 Pulse Oximeters
  • 4.2.5 Respiratory Monitors
  • 4.2.6 Weight Monitors
  • 4.2.7 Temperature Monitors
  • 4.2.8 ECG Devices
  • 4.2.9 Others
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Consultation Services
  • 4.3.2 Device Management Services
  • 4.3.3 Data Management Services
  • 4.3.4 Others
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Wireless Communication
  • 4.4.2 Bluetooth
  • 4.4.3 Wi-Fi
  • 4.4.4 Zigbee
  • 4.4.5 Cellular Networks
  • 4.4.6 Others
• 4.5 Market Size & Forecast by Component (2020-2035)
  • 4.5.1 Sensors
  • 4.5.2 Software
  • 4.5.3 Connectivity Technology
  • 4.5.4 Others
• 4.6 Market Size & Forecast by Application (2020-2035)
  • 4.6.1 Chronic Disease Management
  • 4.6.2 Post-Acute Care
  • 4.6.3 Geriatric Care
  • 4.6.4 Fitness Monitoring
  • 4.6.5 Others
• 4.7 Market Size & Forecast by Device (2020-2035)
  • 4.7.1 Smartphones
  • 4.7.2 Tablets
  • 4.7.3 Wearable Devices
  • 4.7.4 Others
• 4.8 Market Size & Forecast by Deployment (2020-2035)
  • 4.8.1 Cloud-Based
  • 4.8.2 On-Premise
  • 4.8.3 Others
• 4.9 Market Size & Forecast by End User (2020-2035)
  • 4.9.1 Hospitals
  • 4.9.2 Home Care Settings
  • 4.9.3 Clinics
  • 4.9.4 Long-Term Care Centers
  • 4.9.5 Others
• 4.10 Market Size & Forecast by Functionality (2020-2035)
  • 4.10.1 Real-Time Monitoring
  • 4.10.2 Remote Data Transmission
  • 4.10.3 Data Analytics
  • 4.10.4 Alerts and Notifications
  • 4.10.5 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Component
    • 5.2.1.6 Application
    • 5.2.1.7 Device
    • 5.2.1.8 Deployment
    • 5.2.1.9 End User
    • 5.2.1.10 Functionality
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Component
    • 5.2.2.6 Application
    • 5.2.2.7 Device
    • 5.2.2.8 Deployment
    • 5.2.2.9 End User
    • 5.2.2.10 Functionality
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Component
    • 5.2.3.6 Application
    • 5.2.3.7 Device
    • 5.2.3.8 Deployment
    • 5.2.3.9 End User
    • 5.2.3.10 Functionality
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Component
    • 5.3.1.6 Application
    • 5.3.1.7 Device
    • 5.3.1.8 Deployment
    • 5.3.1.9 End User
    • 5.3.1.10 Functionality
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Component
    • 5.3.2.6 Application
    • 5.3.2.7 Device
    • 5.3.2.8 Deployment
    • 5.3.2.9 End User
    • 5.3.2.10 Functionality
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Component
    • 5.3.3.6 Application
    • 5.3.3.7 Device
    • 5.3.3.8 Deployment
    • 5.3.3.9 End User
    • 5.3.3.10 Functionality
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Component
    • 5.4.1.6 Application
    • 5.4.1.7 Device
    • 5.4.1.8 Deployment
    • 5.4.1.9 End User
    • 5.4.1.10 Functionality
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Component
    • 5.4.2.6 Application
    • 5.4.2.7 Device
    • 5.4.2.8 Deployment
    • 5.4.2.9 End User
    • 5.4.2.10 Functionality
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Component
    • 5.4.3.6 Application
    • 5.4.3.7 Device
    • 5.4.3.8 Deployment
    • 5.4.3.9 End User
    • 5.4.3.10 Functionality
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Component
    • 5.4.4.6 Application
    • 5.4.4.7 Device
    • 5.4.4.8 Deployment
    • 5.4.4.9 End User
    • 5.4.4.10 Functionality
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Component
    • 5.4.5.6 Application
    • 5.4.5.7 Device
    • 5.4.5.8 Deployment
    • 5.4.5.9 End User
    • 5.4.5.10 Functionality
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Component
    • 5.4.6.6 Application
    • 5.4.6.7 Device
    • 5.4.6.8 Deployment
    • 5.4.6.9 End User
    • 5.4.6.10 Functionality
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Component
    • 5.4.7.6 Application
    • 5.4.7.7 Device
    • 5.4.7.8 Deployment
    • 5.4.7.9 End User
    • 5.4.7.10 Functionality
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Component
    • 5.5.1.6 Application
    • 5.5.1.7 Device
    • 5.5.1.8 Deployment
    • 5.5.1.9 End User
    • 5.5.1.10 Functionality
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Component
    • 5.5.2.6 Application
    • 5.5.2.7 Device
    • 5.5.2.8 Deployment
    • 5.5.2.9 End User
    • 5.5.2.10 Functionality
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Component
    • 5.5.3.6 Application
    • 5.5.3.7 Device
    • 5.5.3.8 Deployment
    • 5.5.3.9 End User
    • 5.5.3.10 Functionality
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Component
    • 5.5.4.6 Application
    • 5.5.4.7 Device
    • 5.5.4.8 Deployment
    • 5.5.4.9 End User
    • 5.5.4.10 Functionality
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Component
    • 5.5.5.6 Application
    • 5.5.5.7 Device
    • 5.5.5.8 Deployment
    • 5.5.5.9 End User
    • 5.5.5.10 Functionality
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Component
    • 5.5.6.6 Application
    • 5.5.6.7 Device
    • 5.5.6.8 Deployment
    • 5.5.6.9 End User
    • 5.5.6.10 Functionality
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Component
    • 5.6.1.6 Application
    • 5.6.1.7 Device
    • 5.6.1.8 Deployment
    • 5.6.1.9 End User
    • 5.6.1.10 Functionality
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Component
    • 5.6.2.6 Application
    • 5.6.2.7 Device
    • 5.6.2.8 Deployment
    • 5.6.2.9 End User
    • 5.6.2.10 Functionality
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Component
    • 5.6.3.6 Application
    • 5.6.3.7 Device
    • 5.6.3.8 Deployment
    • 5.6.3.9 End User
    • 5.6.3.10 Functionality
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Component
    • 5.6.4.6 Application
    • 5.6.4.7 Device
    • 5.6.4.8 Deployment
    • 5.6.4.9 End User
    • 5.6.4.10 Functionality
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Component
    • 5.6.5.6 Application
    • 5.6.5.7 Device
    • 5.6.5.8 Deployment
    • 5.6.5.9 End User
    • 5.6.5.10 Functionality

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Philips Healthcare
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Medtronic
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 GE Healthcare
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Abbott Laboratories
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Boston Scientific
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Siemens Healthineers
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Johnson and Johnson
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 F. Hoffmann-La Roche
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Omron Healthcare
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Biotronik
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Honeywell Life Sciences
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Smiths Medical
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 iHealth Labs
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Masimo Corporation
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Nihon Kohden
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Hill-Rom Holdings
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 ResMed
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 AliveCor
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Withings
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Dexcom
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us